| Literature DB >> 36231586 |
Kiyoko Saito1, Makiko Komasawa1,2, Myo Nyein Aung2, Ei Thinzar Khin1,2.
Abstract
Globally, 67% of the population has received at least one COVID-19 vaccine dose, but coverage varies across countries. This study aimed to compare people's willingness to receive COVID-19 vaccination across Thailand, Indonesia, Philippines, and Vietnam, where vaccination intention tends to be high, to determine factors associated with willingness, and to obtain suggestions for developing strategies. We conducted a secondary data analysis of the Japan International Cooperation Agency survey "Building Resilience: COVID-19 Impact and Responses in Urban Areas-Case of Southeast Asia," including1842 unvaccinated participants from Thailand (n = 461), Indonesia (n = 246), the Philippines (n = 609), and Vietnam (n = 526). Vaccination willingness was high in all countries (69.6%), but the social and psychological factors motivating people to undergo vaccination differed among these countries. The highest vaccination willingness was in the Philippines, followed by Vietnam and Indonesia, whereas the lowest vaccination willingness was in Thailand. Vaccination willingness was affected by not only sociodemographic attributes, but also risk perception and beliefs, which, in turn, were shaped by social factors such as infection trends and vaccine policies. To achieve effective vaccination promotion programs, a system allowing the flexible modification of promotion methods in response to social conditions must be established.Entities:
Keywords: COVID-19 vaccines; Indonesia; Philippines; Thailand; Vietnam; willingness
Mesh:
Substances:
Year: 2022 PMID: 36231586 PMCID: PMC9566518 DOI: 10.3390/ijerph191912284
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Questions for risk perception of the COVID-19 pandemic.
| Question Items | |
|---|---|
|
| |
| I am well read and know a lot about the coronavirus | |
|
| |
| The world is in serious danger due to the coronavirus | |
| The coronavirus is similar to the regular flu and has similar death rates | |
| People of all ages are dying from the coronavirus | |
| I am safe from the virus where I live, but not the rest of world | |
| Most concerned about older relatives/parents | |
|
| |
| Current pandemic economic is worse than that of Global Financial Crisis of 2008 | |
| I am not financially secure because of the pandemic | |
Questions for reasons (factors) to receive vaccination.
| Positive | Negative |
|---|---|
|
|
|
| It’s free | I do not know when and where to get it |
| Vaccine site is convenient/nearby | I do not have the ability to get an appointment |
| It’s easy to make an appointment | I cannot access an appointment time outside of my working hours |
| My employer provides paid time off to take it | I do not trust the sites where vaccines are being administered |
|
|
|
| Vaccines are safe and effective | Possible side-effects |
| Enough time has passed since people started taking it | Not enough evidence that it prevents COVID 19 |
| Experts say it is safe and effective | Approvals and clinical trials were too fast |
| Recommended by a physician/doctor | Not enough time since people started taking it |
| My loved ones recommended that I take it | Not enough people have taken the vaccine |
| People I know took it | Vaccines are not safe or effective in general |
| Leaders I trust took it | Storage of the vaccine is concerning |
|
| It contained human stem cells in its development |
| I’m afraid of getting COVID 19 | Clinical trials did not include adequate diversity or enough |
| Vaccines will keep my loved ones safe from COVID 19 | I am concerned it will impact my fertility or pregnancy |
|
|
|
| To return to my previous lifestyle | I’m not afraid of getting COVID 19 |
| To return to work/school | I already had COVID 19 |
|
| Religious concerns |
| My employer requires me to take it |
Sociodemographic characteristics of the participants (have not yet been vaccinated).
| Thailand | Indonesia | Philippines | Vietnam |
|
| ||
|---|---|---|---|---|---|---|---|
|
| |||||||
| <35 | 193 (41.9) | 152 (61.8) | 413 (67.8) | 372 (70.7) | 104.05 | <0.001 | |
| ≥35 | 268 (58.1) | 94 (38.2) | 196 (32.2) | 154 (29.3) | |||
|
| |||||||
| Male | 227 (49.2) | 130 (52.8) | 313 (51.4) | 272 (51.7) | 1.04 | 0.79 | |
| Female | 234 (50.8) | 116 (47.2) | 296 (48.6) | 254 (48.3) | |||
|
| |||||||
| Up to secondary | 73 (15.8) | 77 (31.3) | 50 (8.2) | 42 (8.0) | 118.76 | <0.001 | |
| Tertiary and above | 386 (83.7) | 169 (68.7) | 538 (88.3) | 478 (90.9) | |||
| Others | 2 (0.5) | 0 (0.0) | 21 (3.5) | 6 (1.1) | |||
|
| |||||||
| Living alone | 68 (14.7) | 21 (8.5) | 50 (8.2) | 60 (11.4) | 32.72 | <0.001 | |
| Living with friends/partner/spouse with or without children | 224 (48.6) | 158 (64.3) | 314 (51.6) | 303 (57.6) | |||
| Multi-generation | 169 (36.7) | 67 (27.2) | 245 (40.2) | 163 (31.0) | |||
|
| |||||||
| Un-employed | 25 (5.4) | 17 (6.9) | 53 (8.7) | 14 (2.7) | 81.43 | <0.001 | |
| Retired or homemaker | 25 (5.4) | 10 (4.1) | 24 (3.9) | 5 (0.9) | |||
| Part-time | 79 (17.2) | 92 (37.4) | 117 (19.2) | 113 (21.5) | |||
| Full-time or business | 332 (72.0) | 127 (51.6) | 415 (68.2) | 394 (74.9) | |||
|
| |||||||
| Below average | 127 (27.6) | 122 (49.6) | 435 (71.4) | 98 (18.6) | 480.96 | <0.001 | |
| Average | 158 (34.3) | 50 (20.3) | 83 (13.6) | 82 (15.6) | |||
| Above average | 176 (38.2) | 74 (30.1) | 91 (14.9) | 346 (65.8) | |||
|
| |||||||
| Yes | 307 (66.6) | 154 (62.6) | 338 (55.5) | 342 (65.0) | 17.11 | 0.001 | |
| No | 154 (33.4) | 92 (37.4) | 271 (44.5) | 184 (35.0) | |||
Perception about the COVID-19 of the participants not vaccinated yet (frequency).
| Thailand | Indonesia | Philippines | Vietnam |
|
| ||
|---|---|---|---|---|---|---|---|
|
| |||||||
|
| |||||||
| Strongly & somewhat disagree | 29 (6.3) | 18 (7.3) | 85 (14.0) | 24 (4.6) | 95.68 | <0.001 | |
| Neither agree nor disagree | 29 (6.3) | 54 (22.0) | 47 (7.7) | 37 (7.0) | |||
| Strongly & somewhat agree | 403 (87.4) | 174 (70.7) | 477 (78.3) | 465 (88.4) | |||
|
| |||||||
|
| |||||||
| Strongly & somewhat disagree | 270 (58.6) | 108 (43.9) | 290 (47.6) | 364 (69.2) | 76.69 | <0.001 | |
| Neither agree nor disagree | 48 (10.4) | 41 (16.7) | 76 (12.5) | 56 (10.7) | |||
| Strongly & somewhat agree | 143 (31.0) | 97 (39.4) | 243 (39.9) | 106 (20.1) | |||
|
| |||||||
| Strongly & somewhat disagree | 121 (26.2) | 39 (15.9) | 91 (14.9) | 37 (7.0) | 129.92 | <0.001 | |
| Neither agree nor disagree | 72 (15.6) | 53 (21.5) | 44 (7.3) | 44 (8.4) | |||
| Strongly & somewhat agree | 268 (58.1) | 154 (62.6) | 474 (77.8) | 445 (84.6) | |||
|
| |||||||
| Strongly & somewhat disagree | 27 (5.8) | 20 (8.1) | 32 (5.2) | 13 (2.5) | 49.78 | <0.001 | |
| Neither agree nor disagree | 28 (6.1) | 36 (14.7) | 34 (5.6) | 20 (3.8) | |||
| Strongly & somewhat agree | 406 (88.1) | 190 (77.2) | 543 (89.2) | 493 (93.7) | |||
|
| |||||||
| Strongly & somewhat agree | 91 (19.7) | 108 (43.9) | 220 (36.1) | 274 (52.1) | 231.91 | <0.001 | |
| Neither agree nor disagree | 38 (8.3) | 66 (26.8) | 134 (22.0) | 98 (18.6) | |||
| Strongly & somewhat disagree | 332 (72.0) | 72 (29.3) | 255 (41.9) | 154 (29.3) | |||
|
| |||||||
| Strongly & somewhat disagree | 24 (5.2) | 17 (6.9) | 52 (8.6) | 28 (5.3) | 71.15 | <0.001 | |
| Neither agree nor disagree | 27 (5.9) | 42 (17.1) | 13 (2.1) | 52 (9.9) | |||
| Strongly & somewhat agree | 410 (88.9) | 187 (76.0) | 544 (89.3) | 446 (84.8) | |||
|
| |||||||
|
| |||||||
| Strongly & somewhat disagree | 26 (5.6) | 49 (19.9) | 43 (7.1) | 49 (9.3) | 83.09 | <0.001 | |
| Neither agree nor disagree | 58 (12.6) | 59 (24.0) | 107 (17.6) | 132 (25.1) | |||
| Strongly & somewhat agree | 377 (81.8) | 138 (56.1) | 459 (75.31) | 345 (65.6) | |||
|
| |||||||
| Strongly & somewhat disagree | 30 (6.5) | 35 (14.2) | 95 (15.6) | 84 (16.0) | 113.82 | <0.001 | |
| Neither agree nor disagree | 46 (10.0 | 58 (23.6) | 96 (15.8) | 159 (30.2) | |||
| Strongly & somewhat agree | 385 (83.5) | 153 (62.2) | 418 (68.6) | 283 (53.8) | |||
COVID-19 Vaccination Characteristics.
|
|
|
|
|
|
|
| ||
|
| ||||||||
| Yes | 605 (59.9) | 668 (65.6) | 690 (68.2) | 721 (69.9) | 2684 (65.9) | 69.48 | <0.001 | |
| No | 158 (15.6) | 183 (18.0) | 92 (9.1) | 104 (10.1) | 537 (13.2) | |||
| Don’t know | 247 (24.5) | 167 (16.4) | 230 (22.7) | 207 (20.0) | 851 (20.9) | |||
|
|
|
|
|
|
|
| ||
|
| ||||||||
| Yes | 144 (23.8) | 422 (63.2) | 81 (11.7) | 195 (27.1) | 842 (31.4) | 459.69 | <0.001 | |
| No | 461 (76.2) | 246 (36.8) | 609 (88.3) | 526 (72.9) | 1842 (68.6) | |||
|
|
|
|
|
|
|
| ||
|
| ||||||||
| Highly & somewhat unlikely | 50 (10.9) | 11 (4.5) | 44 (7.2) | 48 (9.2) | 153 (8.3) | 28.02 | <0.001 | |
| May be | 120 (26.0) | 66 (26.8) | 104 (17.1) | 117 (22.2) | 407 (22.1) | |||
| Highly & somewhat likely | 291 (63.1) | 169 (68.7) | 461 (75.7) | 361 (68.6) | 1282 (69.6) | |||
Positive reasons (factors) for vaccination.
| Positive | Thailand | Indonesia | Philippines | Vietnam |
|
| |
|---|---|---|---|---|---|---|---|
|
| |||||||
| It’s free | |||||||
| Not selected | 284 (61.6) | 175 (71.1) | 437 (71.8) | 433 (82.3) | 52.75 | <0.001 | |
| Selected | 177 (38.4) | 71 (28.9) | 172 (28.2) | 93 (17.7) | |||
| Vaccine site is convenient/nearby | |||||||
| Not selected | 404 (87.6) | 208 (84.5) | 582 (95.6) | 473 (89.9) | 32.90 | <0.001 | |
| Selected | 57 (12.4) | 38 (15.5) | 27 (4.4) | 53 (10.1) | |||
| It is easy to make an appointment | |||||||
| Not selected | 425 (92.2) | 222 (90.2) | 599 (98.4) | 503 (95.6) | 33.94 | <0.0001 | |
| Selected | 36 (7.8) | 24 (9.8) | 10 (1.6) | 23 (4.4) | |||
| My employer provides paid time off to take it | |||||||
| Not selected | 444 (96.3) | 232 (94.3) | 573 (94.1) | 503 (95.6) | 3.44 | 0.33 | |
| Selected | 17 (3.7) | 14 (5.7) | 36 (5.9) | 23 (4.4) | |||
|
| |||||||
| Vaccines are safe and effective | |||||||
| Not selected | 303 (65.7) | 170 (69.1) | 418 (68.6) | 251 (47.7) | 64.91 | <0.001 | |
| Selected | 158 (34.3) | 76 (30.9) | 191 (31.4) | 275 (52.3) | |||
| Enough time has passed since people started taking it | |||||||
| Not selected | 417 (90.5) | 221 (89.8) | 576 (94.6) | 499 (94.9) | 13.51 | 0.004 | |
| Selected | 44 (9.5) | 25 (10.2) | 33 (5.4) | 27 (5.1) | |||
| Experts say it is safe and effective | |||||||
| Not selected | 354 (76.8) | 167 (67.9) | 376 (61.7) | 382 (72.6) | 21.54 | <0.001 | |
| Selected | 107 (23.2) | 79 (32.1) | 233 (38.3) | 144 (27.4) | |||
| Recommended by a physician/doctor | |||||||
| Not selected | 378 (82.0) | 196 (79.7) | 508 (83.4) | 464 (88.2) | 11.86 | <0.00 | |
| Selected | 83 (18.0) | 50 (30.3) | 101 (16.6) | 62 (11.8) | |||
| My loved ones recommended that I take it | |||||||
| Not selected | 433 (93.9) | 213 (86.6) | 569 (93.4) | 483 (91.8) | 14.05 | 0.003 | |
| Selected | 28 (6.1) | 33 (13.4) | 40 (6.6) | 43 (8.2) | |||
| People I know took it | |||||||
| Not selected | 436 (94.6) | 218 (88.6) | 577 (94.8) | 487 (92.6) | 12.24 | 0.01 | |
| Selected | 25 (5.4) | 28 (11.4) | 32 (5.2) | 39 (7.4) | |||
| Leaders I trust took it | |||||||
| Not selected | 432 (93.7) | 219 (89.0) | 588 (96.5) | 476 (90.5) | 23.50 | <0.001 | |
| Selected | 29 (6.3) | 27 (11.0) | 21 (3.5) | 50 (9.5) | |||
|
| |||||||
| I’m afraid of getting COVID 19 | |||||||
| Not selected | 280 (60.7) | 178 (72.4) | 353 (58.0) | 252 (47.9) | 44.08 | <0.001 | |
| Selected | 181 (39.3) | 68 (27.6) | 256 (42.0) | 274 (52.1) | |||
| Vaccines will keep my loved ones safe from COVID 19 | |||||||
| Not selected | 259 (56.2) | 146 (59.4) | 271 (44.5) | 294 (55.9) | 25.19 | <0.001 | |
| Selected | 202 (43.8) | 100 (40.6) | 338 (55.5) | 232 (44.1) | |||
|
| |||||||
| To return to my previous lifestyle | |||||||
| Not selected | 326 (70.7) | 212 (86.2) | 476 (78.2) | 427 (81.2) | 27.10 | <0.001 | |
| Selected | 135 (29.3) | 34 (13.8) | 133 (21.8) | 99 (18.8) | |||
| To return to work/school | |||||||
| Not selected | 415 (90.0) | 207 (84.2) | 513 (84.2) | 451 (85.7) | 8.53 | 0.04 | |
| Selected | 46 (10.0) | 39 (15.8) | 96 (15.8) | 75 (14.3) | |||
|
| |||||||
| My employer requires me to take it | |||||||
| Not selected | 428 (92.8) | 232 (94.3) | 533 (87.5) | 488 (92.8) | 16.50 | 0.001 | |
| Selected | 33 (7.2) | 14 (5.7) | 76 (12.5) | 38 (7.2) | |||
| Others | |||||||
| Not selected | 457 (99.1) | 245 (99.6) | 605 (99.3) | 536 (100.0) | 4.33 | 0.23 | |
| Selected | 4 (0.9) | 1 (0.4) | 4 (0.7) | 0 (0.0) | |||
Negative reasons (factors) for vaccination.
| Negative | Thailand | Indonesia | Philippines | Vietnam |
|
| |
|---|---|---|---|---|---|---|---|
|
| |||||||
| I do not know when and where to get it | |||||||
| Not selected | 409 (88.7) | 179 (72.8) | 523 (85.9) | 372 (70.7) | 72.51 | <0.001 | |
| Selected | 52 (11.3) | 67 (27.2) | 86 (14.1) | 154 (29.3) | |||
| I do not have the ability to get an appointment | |||||||
| Not selected | 417 (90.5) | 201 (81.7) | 541 (88.8) | 442 (84.0) | 16.77 | 0.001 | |
| Selected | 44 (9.5) | 45 (18.3) | 68 (11.2) | 84 (16.0) | |||
| I cannot access an appointment time outside of my working hours | |||||||
| Not selected | 431 (93.5) | 208 (84.5) | 561 (92.1) | 477 (90.7) | 17.04 | 0.001 | |
| Selected | 30 (6.5) | 38 (15.5) | 48 (7.9) | 49 (9.3) | |||
| I do not trust the sites where vaccines are being administered | |||||||
| Not selected | 418 (90.7) | 217 (88.2) | 502 (82.4) | 460 (87.5) | 16.68 | 0.001 | |
| Selected | 43 (9.3) | 29 (11.8) | 107 (17.6) | 66 (12.5) | |||
|
| |||||||
| Possible side-effects | |||||||
| Not selected | 111 (24.1) | 115 (46.7) | 164 (26.9) | 234 (44.5) | 77.51 | <0.001 | |
| Selected | 350 (75.9) | 131 (53.3) | 445 (73.1) | 292 (55.5) | |||
| Not enough people have taken the vaccine | |||||||
| Not selected | 424 (92.0) | 206 (83.7) | 494 (81.1) | 449 (85.4) | 25.48 | <0.001 | |
| Selected | 37 (8.0) | 40 (16.3) | 115 (18.9) | 77 (14.6) | |||
| Approvals and clinical trials were too fast | |||||||
| Not selected | 398 (86.3) | 206 (83.7) | 439 (72.1) | 465 (88.4) | 61.17 | <0.001 | |
| Selected | 63 (13.7) | 40 (16.3) | 170 (27.9) | 61 (11.6) | |||
| Not enough evidence that it prevents COVID 19 | |||||||
| Not selected | 300 (65.1) | 187 (76.0) | 384 (63.1) | 398 (75.7) | 29.90 | <0.001 | |
| Selected | 161 (34.9) | 59 (24.0) | 225 (36.9) | 128 (24.3) | |||
| Not enough time since people started taking it | |||||||
| Not selected | 425 (92.2) | 214 (87.0) | 539 (88.5) | 432 (82.1) | 23.60 | <0.001 | |
| Selected | 36 (7.8) | 32 (13.0) | 70 (11.5) | 94 (17.9) | |||
| Vaccines are not safe or effective in general | |||||||
| Not selected | 174 (37.7) | 214 (87.0) | 499 (81.9) | 460 (87.5) | 396.75 | <0.001 | |
| Selected | 287 (62.3) | 32 (13.0) | 110 (18.1) | 66 (12.5) | |||
| Storage of the vaccine is concerning | |||||||
| Not selected | 416 (90.2) | 210 (85.4) | 543 (89.2) | 414 (78.7) | 35.12 | <0.001 | |
| Selected | 45 (9.8) | 36 (14.6) | 66 (10.8) | 112 (21.3) | |||
| It contained human stem cells in its development | |||||||
| Not selected | 429 (93.1) | 224 (91.1) | 584 (95.9) | 475 (90.3) | 15.02 | 0.002 | |
| Selected | 32 (6.9) | 22 (8.9) | 25 (4.1) | 51 (9.7) | |||
| Clinical trials did not include adequate diversity or enough people of color | |||||||
| Not selected | 400 (86.8) | 208 (84.5) | 491 (80.6) | 445 (84.6) | 7.88 | 0.05 | |
| Selected | 61 (13.2) | 38 (15.5) | 118 (19.4) | 81 (15.4) | |||
| I am concerned it will impact my fertility or pregnancy | |||||||
| Not selected | 418 (90.7) | 212 (86.2) | 565 (92.8) | 423 (80.4) | 45.11 | <0.001 | |
| Selected | 43 (9.3) | 34 (13.8) | 44 (7.2) | 103 (19.6) | |||
| Others | |||||||
| Not selected | 448 (97.2) | 242 (98.4) | 594 (97.5) | 516 (98.1) | 1.51 | 0.68 | |
| Selected | 13 (2.8) | 4 (1.6) | 15 (2.5) | 10 (1.9) | |||
|
| |||||||
| I’m not afraid of getting COVID 19 | |||||||
| Not selected | 440 (95.4) | 225 (91.1) | 560 (91.9) | 498 (94.7) | 8.86 | 0.03 | |
| Selected | 21 (4.6) | 22 (8.9) | 49 (8.1) | 28 (5.3) | |||
| I already had COVID 19 | |||||||
| Not selected | 452 (98.1) | 229 (93.1) | 603 (99.0) | 512 (97.3) | 26.02 | <0.001 | |
| Selected | 9 (1.9) | 17 (6.9) | 6 (1.0) | 14 (2.7) | |||
| Religious concerns | |||||||
| Not selected | 455 (98.7) | 229 (93.1) | 588 (96.5) | 501 (92.3) | 16.10 | 0.001 | |
| Selected | 6 (1.3) | 17 (6.9) | 21 (3.5) | 25 (4.7) | |||
Binomial logistic regression of willingness for vaccine with sociodemographic factors.
| Thailand | Indonesia | Philippines | Vietnam | ||||||
|---|---|---|---|---|---|---|---|---|---|
| AOR (95% CI) |
| AOR (95% CI) |
| AOR (95% CI) |
| AOR (95% CI) |
| ||
|
| |||||||||
| ≤34 | 1 | 1 | 1 | 1 | |||||
| >34 | 1.20 | 0.38 | 2.35 | <0.05 | 1.27 | 0.28 | 0.50 | <0.05 | |
|
| |||||||||
| Male | 1 | 1 | 1 | 1 | |||||
| Female | 0.70 | 0.09 | 0.87 | 0.66 | 0.96 | 0.86 | 1.34 | 0.15 | |
|
| |||||||||
| Below average | 1 | 1 | 1 | 1 | |||||
| Average | 1.43 | 0.18 | 1.73 | 0.21 | 0.96 | 0.89 | 0.81 | 0.52 | |
| Above average | 0.89 | 0.67 | 1.05 | 0.90 | 1.20 | 0.55 | 1.87 | <0.05 | |
|
| |||||||||
| No | 1 | 1 | 1 | 1 | |||||
| Yes | 0.90 | 0.63 | 1.97 | <0.05 | 0.88 | 0.52 | 1.47 | 0.07 | |
|
| |||||||||
| Up to secondary | 1 | 1 | 1 | 1 | |||||
| Tertiary and above | 2.25 | <0.05 | 2.46 | <0.05 | 1.60 | 0.15 | 1.63 | 0.17 | |
|
| |||||||||
| Un-employed | 1 | 1 | 1 | 1 | |||||
| Retired or homemaker | 5.19 | <0.05 | 1.47 | 0.72 | 0.60 | 0.35 | 2.16 | 0.49 | |
| Part-time | 0.89 | 0.79 | 0.80 | 0.74 | 1.20 | 0.64 | 2.01 | 0.27 | |
| Full-time or business | 1.68 | 0.24 | 0.99 | 0.99 | 1.25 | 0.51 | 4.43 | <0.05 | |
|
| |||||||||
| Living alone | 1 | ||||||||
| Living with friends/partner/spouse with or without children | 1.19 | 0.56 | 0.80 | 0.68 | 1.08 | 0.82 | 0.86 | 0.67 | |
| Multi-generation | 1.10 | 0.76 | 1.03 | 0.96 | 1.10 | 0.80 | 0.39 | <0.05 | |
Binomial logistic regression of willingness for vaccine with virus perception.
| Thailand | Indonesia | Philippines | Vietnam | ||||||
|---|---|---|---|---|---|---|---|---|---|
| AOR (95% CI) |
| AOR (95% CI) |
| AOR (95% CI) |
| AOR (95% CI) |
| ||
|
| |||||||||
|
| |||||||||
| Strongly & somewhat disagree | 1 | 1 | 1 | 1 | |||||
| Neither agree nor disagree | 1.41 | 0.56 | 0.85 | 0.82 | 0.47 | 0.09 | 0.30 | 0.05 | |
| Strongly & somewhat agree | 2.07 | 0.08 | 1.04 | 0.96 | 0.73 | 0.33 | 0.82 | 0.69 | |
|
| |||||||||
|
| |||||||||
| Strongly & somewhat agree | 1 | 1 | 1 | 1 | |||||
| Neither agree nor disagree | 1.07 | 0.86 | 0.74 | 0.55 | 0.45 | <0.05 | 0.72 | 0.39 | |
| Strongly & somewhat disagree | 1.41 | 0.17 | 0.79 | 0.53 | 0.96 | 0.88 | 1.13 | 0.62 | |
|
| |||||||||
| Strongly & somewhat disagree | 1 | 1 | 1 | 1 | |||||
| Neither agree nor disagree | 1.35 | 0.38 | 1.22 | 0.71 | 2.32 | 0.07 | 0.62 | 0.34 | |
| Strongly & somewhat agree | 1.16 | 0.56 | 1.51 | 0.39 | 1.77 | <0.05 | 1.65 | 0.20 | |
|
| |||||||||
| Strongly & somewhat disagree | 1 | 1 | 1 | 1 | |||||
| Neither agree nor disagree | 0.51 | 0.28 | 3.26 | 0.11 | 1.19 | 0.75 | 0.63 | 0.59 | |
| Strongly & somewhat agree | 0.66 | 0.37 | 8.28 | <0.05 | 3.22 | <0.05 | 0.89 | 0.87 | |
|
| |||||||||
| Strongly & somewhat agree | 1 | 1 | 1 | 1 | |||||
| Neither agree nor disagree | 0.53 | 0.17 | 0.63 | 0.26 | 0.52 | <0.05 | 1.61 | 0.10 | |
| Strongly & somewhat disagree | 0.59 | 0.07 | 1.18 | 0.69 | 0.88 | 0.61 | 1.00 | 0.99 | |
|
| |||||||||
| Strongly & somewhat disagree | 1 | 1 | 1 | 1 | |||||
| Neither agree nor disagree | 2.12 | 0.28 | 3.98 | 0.07 | 1.49 | 0.62 | 0.73 | 0.58 | |
| Strongly & somewhat agree | 0.95 | 0.91 | 4.47 | <0.05 | 0.98 | 0.95 | 0.89 | 0.80 | |
|
| |||||||||
|
| |||||||||
| Strongly & somewhat disagree | 1 | 1 | 1 | 1 | |||||
| Neither agree nor disagree | 1.12 | 0.83 | 1.05 | 0.91 | 1.35 | 0.49 | 1.11 | 0.79 | |
| Strongly & somewhat agree | 0.71 | 0.46 | 1.55 | 0.31 | 1.57 | 0.24 | 1.33 | 0.40 | |
|
| |||||||||
| Strongly & somewhat disagree | 1 | 1 | 1 | 1 | |||||
| Neither agree nor disagree | 1.08 | 0.89 | 0.24 | <0.05 | 1.59 | 0.21 | 1.14 | 0.66 | |
| Strongly & somewhat agree | 0.69 | 0.41 | 0.38 | 0.09 | 1.09 | 0.76 | 1.28 | 0.37 | |
Binomial logistic regression of willingness for vaccine with positive reasons (factor) to vaccination.
| Willingness for vaccination (Unlikely = 0, Likely = 1) | Thailand | Indonesia | Philipines | Vietnam | |||||
|---|---|---|---|---|---|---|---|---|---|
| Positive | AOR |
| AOR |
| AOR |
| AOR |
| |
|
| |||||||||
| It’sfree | 0.57 | <0.01 | 0.46 | <0.05 | 0.64 | <0.05 | 0.98 | 0.96 | |
| Vaccinesiteisconvenient/nearby | 0.72 | 0.28 | 0.47 | 0.07 | 0.50 | 0.10 | 1.23 | 0.55 | |
| Easytomakeanappointment | 0.95 | 0.90 | 0.76 | 0.58 | 0.31 | 0.07 | 2.48 | 0.13 | |
| Myemployerprovidespaidtimeofftotakeit | 1.43 | 0.52 | 0.64 | 0.48 | 0.70 | 0.37 | 1.33 | 0.58 | |
|
| |||||||||
| Vaccines are safe and effective | 0.68 | 0.07 | 0.86 | 0.66 | 1.40 | 0.12 | 1.14 | 0.52 | |
| Enough time has passed since people started taking it | 0.34 | <0.01 | 4.27 | <0.05 | 0.49 | 0.06 | 0.32 | <0.01 | |
| Experts say it is safe and effective | 0.61 | <0.05 | 1.31 | 0.41 | 1.30 | 0.19 | 0.88 | 0.58 | |
| Recommended by a physician/doctor | 0.98 | 0.94 | 1.19 | 0.64 | 0.84 | 0.49 | 0.71 | 0.25 | |
| My loved ones recommended that I take it | 1.07 | 0.88 | 0.74 | 0.47 | 1.39 | 0.43 | 1.40 | 0.40 | |
| People I know took it | 1.83 | 0.22 | 0.79 | 0.64 | 0.51 | 0.08 | 0.88 | 0.74 | |
| Leaders I trust took it | 0.96 | 0.91 | 0.57 | 0.22 | 0.91 | 0.85 | 1.10 | 0.27 | |
|
| |||||||||
| I’m afraid of getting COVID 19 | 1.38 | 0.13 | 1.43 | 0.29 | 1.97 | <0.01 | 1.03 | 0.88 | |
| Vaccines will keep my loved ones safe from COVID 19 | 2.49 | <0.001 | 5.09 | <0.001 | 1.65 | <0.05 | 1.49 | 0.06 | |
|
| |||||||||
| To return to my previous lifestyle | 1.27 | 0.29 | 0.77 | 0.54 | 1.25 | 0.35 | 0.76 | 0.28 | |
| To return to work/school | 1.64 | 0.17 | 0.77 | 0.51 | 0.85 | 0.52 | 1.09 | 0.77 | |
|
| |||||||||
| My employer requires me to take it | 1.86 | 0.16 | 0.67 | 0.53 | 0.45 | <0.01 | 0.83 | 0.65 | |
Binomial logistic regression of willingness for vaccine with negative reasons (factor) to vaccination.
| Willingness for vaccination (Unlikely = 0, Likely = 1) | Thailand | Indonesia | Philipines | Vietnam | |||||
|---|---|---|---|---|---|---|---|---|---|
| Negative | AOR |
| AOR |
| AOR |
| AOR |
| |
|
| |||||||||
| I do not know when and where to get it | 0.84 | 0.58 | 1.35 | 0.39 | 1.42 | 0.23 | 1.05 | 0.82 | |
| I do not have the ability to get an appointment | 3.85 | <0.01 | 1.01 | 0.97 | 3.36 | <0.01 | 1.29 | 0.39 | |
| I cannot access an appointment time outside of my working hours | 2.36 | 0.07 | 1.25 | 0.58 | 1.60 | 0.24 | 1.38 | 0.37 | |
| I do not trust the sites where vaccines are being administered | 1.08 | 0.82 | 0.25 | <0.01 | 1.03 | 0.90 | 1.14 | 0.67 | |
|
| |||||||||
| Possible side-effects | 0.66 | 0.09 | 0.90 | 0.73 | 0.86 | 0.50 | 0.53 | <0.01 | |
| Not enough evidence that it prevents COVID 19 | 0.54 | <0.01 | 1.17 | 0.67 | 0.58 | <0.01 | 0.70 | 0.13 | |
| Approvals and clinical trials were too fast | 2.11 | <0.05 | 2.29 | 0.07 | 0.69 | 0.08 | 1.07 | 0.83 | |
| Not enough time since people started taking it | 0.80 | 0.56 | 1.04 | 0.93 | 0.95 | 0.88 | 0.84 | 0.51 | |
| Not enough people have taken the vaccine | 1.99 | 0.09 | 0.62 | 0.23 | 0.76 | 0.24 | 0.84 | 0.55 | |
| Vaccines are not safe or effective in general | 0.43 | <0.001 | 0.77 | 0.54 | 0.57 | <0.05 | 0.97 | 0.93 | |
| Storage of the vaccine is concerning | 0.72 | 0.33 | 1.59 | 0.29 | 1.24 | 0.50 | 1.67 | 0.06 | |
| It contained human stem cells in its development | 2.14 | 0.09 | 0.96 | 0.95 | 1.30 | 0.61 | 3.92 | <0.01 | |
| Clinical trials did not include adequate diversity or enough | 1.18 | 0.59 | 1.12 | 0.78 | 1.39 | 0.20 | 1.22 | 0.48 | |
| I am concerned it will impact my fertility or pregnancy | 2.22 | <0.05 | 1.59 | 0.30 | 0.89 | 0.74 | 1.32 | 0.31 | |
|
| |||||||||
| I’m not afraid of getting COVID 19 | 0.88 | 0.79 | 0.63 | 0.37 | 2.22 | 0.06 | 1.07 | 0.88 | |
| Religious concerns | 1.04 | 0.96 | 0.45 | 0.17 | 1.46 | 0.51 | 1.04 | 0.94 | |
| I already had COVID-19 | 4.92 | 0.14 | 1.47 | 0.54 | 1.45 | 0.74 | 0.55 | 0.32 | |
Figure 1Number of new infections.